91 related articles for article (PubMed ID: 11295049)
21. Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
Cohen MB; Glazer RI
Mol Pharmacol; 1985 Feb; 27(2):308-13. PubMed ID: 2578606
[TBL] [Abstract][Full Text] [Related]
22. In vitro translational activity of messenger RNA following treatment of human colon carcinoma cells with sangivamycin.
Glazer RI; Hartman KD
Mol Pharmacol; 1983 Nov; 24(3):509-12. PubMed ID: 6633511
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
24. Kinetic effects of sangivamycin in sarcoma 180 in vitro.
Ritch PS; Glazer RI; Cunningham RE; Shackney SE
Cancer Res; 1981 May; 41(5):1784-8. PubMed ID: 7214345
[TBL] [Abstract][Full Text] [Related]
25. Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.
Loomis CR; Bell RM
J Biol Chem; 1988 Feb; 263(4):1682-92. PubMed ID: 3338987
[TBL] [Abstract][Full Text] [Related]
26. Deciphering deazapurine biosynthesis: pathway for pyrrolopyrimidine nucleosides toyocamycin and sangivamycin.
McCarty RM; Bandarian V
Chem Biol; 2008 Aug; 15(8):790-8. PubMed ID: 18721750
[TBL] [Abstract][Full Text] [Related]
27. Comparison between the inhibitory activities of sangivamycin and thiosangivamycin on nuclear ribonucleic acid synthesis in L1210 cells in vitro.
Glazer RI; Peale AL
Biochem Pharmacol; 1980 Feb; 29(3):305-10. PubMed ID: 7362643
[No Abstract] [Full Text] [Related]
28. In vitro effect of cyclosporin A, mitomycin C and prednisolone on cell kinetics in cultured human umbilical vein endothelial cells.
Seki Y; Toba K; Fuse I; Sato N; Niwano H; Takahashi H; Tanabe N; Aizawa Y
Thromb Res; 2005; 115(3):219-28. PubMed ID: 15617745
[TBL] [Abstract][Full Text] [Related]
29. Effect of sangivamycin and xylosyladenine on the synthesis and methylation of polysomal ribonucleic acid in Ehrlich ascites cells in vitro.
Glazer RI; Hartman KD; Cohen OJ
Biochem Pharmacol; 1981 Oct; 30(19):2697-701. PubMed ID: 7295353
[No Abstract] [Full Text] [Related]
30. Synthesis and in vitro antitumor activity of some amino-deoxy 7-hexofuranosylpyrrolo[2,3-d]pyrimidines.
Huang BG; Bobek M
Carbohydr Res; 1998 Jun; 308(3-4):319-28. PubMed ID: 9711826
[TBL] [Abstract][Full Text] [Related]
31. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
32. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
Shekhar MP; Werdell J; Tait L
Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
[TBL] [Abstract][Full Text] [Related]
33. Antiviral activity of C-5 substituted tubercidin analogues.
Bergstrom DE; Brattesani AJ; Ogawa MK; Reddy PA; Schweickert MJ; Balzarini J; De Clercq E
J Med Chem; 1984 Mar; 27(3):285-92. PubMed ID: 6699874
[TBL] [Abstract][Full Text] [Related]
34. Antagonism of the cytotoxic but not antiviral effects of ara-sangivamycin by adenosine.
Birch GM; Krawczyk SH; Townsend LB; Drach JC
Antimicrob Agents Chemother; 1989 Sep; 33(9):1606-8. PubMed ID: 2554803
[TBL] [Abstract][Full Text] [Related]
35. MAPK phosphatase-1 contributes to trichostatin A inhibition of cyclooxygenase-2 expression in human umbilical vascular endothelial cells exposed to lipopolysaccharide.
Hsu YF; Sheu JR; Lin CH; Chen WC; Hsiao G; Ou G; Chiu PT; Hsu MJ
Biochim Biophys Acta; 2011 Dec; 1810(12):1160-9. PubMed ID: 21911040
[TBL] [Abstract][Full Text] [Related]
36. Newly synthesized quinazolinone HMJ-38 suppresses angiogenetic responses and triggers human umbilical vein endothelial cell apoptosis through p53-modulated Fas/death receptor signaling.
Chiang JH; Yang JS; Lu CC; Hour MJ; Chang SJ; Lee TH; Chung JG
Toxicol Appl Pharmacol; 2013 Jun; 269(2):150-62. PubMed ID: 23523585
[TBL] [Abstract][Full Text] [Related]
37. Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines.
Seki M; Toi M; Kobayashi K; Shitara K; Umezawa K; Seon BK; Kan M; Rhim JS
Int J Oncol; 2000 Sep; 17(3):525-33. PubMed ID: 10938394
[TBL] [Abstract][Full Text] [Related]
38. Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells.
Varghese S; Ramsby ML; Jeffrey JJ; Canalis E
Endocrinology; 1995 May; 136(5):2156-62. PubMed ID: 7720665
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine phosphatase regulation of endothelial cell apoptosis and differentiation.
Yang C; Chang J; Gorospe M; Passaniti A
Cell Growth Differ; 1996 Feb; 7(2):161-71. PubMed ID: 8822199
[TBL] [Abstract][Full Text] [Related]
40. 2,3,7,8-Tetrachlorodibenzo-p-dioxin differentially suppresses angiogenic responses in human placental vein and artery endothelial cells.
Li Y; Wang K; Zou QY; Magness RR; Zheng J
Toxicology; 2015 Oct; 336():70-8. PubMed ID: 26275813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
